125 related articles for article (PubMed ID: 29342193)
1. Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
Jones DC; Scanteianu A; DiStefano M; Bouhaddou M; Birtwistle MR
PLoS One; 2018; 13(1):e0190664. PubMed ID: 29342193
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
Lehrer S; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
[TBL] [Abstract][Full Text] [Related]
3. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
4. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
[TBL] [Abstract][Full Text] [Related]
6. GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
Lee CH; Alpert BO; Sankaranarayanan P; Alter O
PLoS One; 2012; 7(1):e30098. PubMed ID: 22291905
[TBL] [Abstract][Full Text] [Related]
7. An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma.
Feng J; Kim ST; Liu W; Kim JW; Zhang Z; Zhu Y; Berens M; Sun J; Xu J
Cancer; 2012 Jan; 118(1):232-40. PubMed ID: 21713760
[TBL] [Abstract][Full Text] [Related]
8. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.
Skoda J; Neradil J; Zitterbart K; Sterba J; Veselska R
Oncol Rep; 2014 Jan; 31(1):480-7. PubMed ID: 24270553
[TBL] [Abstract][Full Text] [Related]
9. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.
Hodgson JG; Yeh RF; Ray A; Wang NJ; Smirnov I; Yu M; Hariono S; Silber J; Feiler HS; Gray JW; Spellman PT; Vandenberg SR; Berger MS; James CD
Neuro Oncol; 2009 Oct; 11(5):477-87. PubMed ID: 19139420
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
[TBL] [Abstract][Full Text] [Related]
11. Copy number profiling across glioblastoma populations has implications for clinical trial design.
Cimino PJ; McFerrin L; Wirsching HG; Arora S; Bolouri H; Rabadan R; Weller M; Holland EC
Neuro Oncol; 2018 Sep; 20(10):1368-1373. PubMed ID: 29982740
[TBL] [Abstract][Full Text] [Related]
12. A genetic risk score for glioblastoma multiforme based on copy number variations.
Ko C; Brody JP
Cancer Treat Res Commun; 2021; 27():100352. PubMed ID: 33756171
[TBL] [Abstract][Full Text] [Related]
13. IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals.
Ping Y; Zhang H; Deng Y; Wang L; Zhao H; Pang L; Fan H; Xu C; Li F; Zhang Y; Gong Y; Xiao Y; Li X
Mol Biosyst; 2014 Aug; 10(8):2031-42. PubMed ID: 24911613
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathologic diagnosis of epidermal growth factor receptor.
Maire CL; Ligon KL
Neuro Oncol; 2014 Oct; 16 Suppl 8(Suppl 8):viii1-6. PubMed ID: 25342599
[TBL] [Abstract][Full Text] [Related]
15. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
Gu Y; Wang H; Qin Y; Zhang Y; Zhao W; Qi L; Zhang Y; Wang C; Guo Z
Mol Biosyst; 2013 Mar; 9(3):467-77. PubMed ID: 23344900
[TBL] [Abstract][Full Text] [Related]
16. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
[TBL] [Abstract][Full Text] [Related]
17. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
Khatri RG; Navaratne K; Weil RJ
J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
[TBL] [Abstract][Full Text] [Related]
18. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
[TBL] [Abstract][Full Text] [Related]
19. Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition.
Aiello KA; Alter O
PLoS One; 2016; 11(10):e0164546. PubMed ID: 27798635
[TBL] [Abstract][Full Text] [Related]
20. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
Zheng S; Wu Y; Li Z
Radiother Oncol; 2021 Jan; 154():36-44. PubMed ID: 32918970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]